Diagnostic and prognostic performance of the fibrotic nonalcoholic steatohepatitis index in patients with metabolic dysfunction-associated steatotic liver disease
{{output}}
Background and aims: Identifying patients with fibrotic metabolic dysfunction-associated steatohepatitis (MASH) is crucial in order to refer them to specialist care as fibrotic MASH represents one of the major inclusion criteria ... ...
